PubMed

Discovery of a human peptide sequence signaling islet neogenesis.

Levetan CS, Upham LV, Deng S, Laury-Kleintop L, Kery V, Nolan R, Quinlan J, Torres C, El-Hajj RJ.

Endocr Pract. 2008 Dec;14(9):1075-83.PMID: 19158046 [PubMed - indexed for MEDLINE]Related articles

Oral antidiabetic agents in type 2 diabetes.

Levetan C.

Curr Med Res Opin. 2007 Apr;23(4):945-52. Review.PMID: 17407651 [PubMed - indexed for MEDLINE]Related articles

Impact of computer-generated personalized goals on cholesterol lowering.

Levetan CS, Dawn KR, Murray JF, Popma JJ, Ratner RE, Robbins DC.

Value Health. 2005 Nov-Dec;8(6):639-46.PMID: 16283864 [PubMed - indexed for MEDLINE]Related articles

Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial.

Tanenberg R, Bode B, Lane W, Levetan C, Mestman J, Harmel AP, Tobian J, Gross T, Mastrototaro J.

Mayo Clin Proc. 2004 Dec;79(12):1521-6.PMID: 15595336 [PubMed - indexed for MEDLINE]Related articlesFree article

Hemoglobin A1c: need to standardize the term.

Levetan CS.

Endocr Pract. 2002;8 Suppl 1:25-6.PMID: 15251847 [PubMed - indexed for MEDLINE]Related articles

Effect of hyperglycemia on stroke outcomes.

Levetan CS.

Endocr Pract. 2004 Mar-Apr;10 Suppl 2:34-9. Review.PMID: 15251638 [PubMed - indexed for MEDLINE]Related articles

Type 2 diabetes: the role of basal insulin therapy.

LeRoith D, Levetan CS, Hirsch IB, Riddle MC.

J Fam Pract. 2004 Mar;53(3):215-22. No abstract available. PMID: 15000929 [PubMed - indexed for MEDLINE]Related articles

Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps.

Levetan C, Want LL, Weyer C, Strobel SA, Crean J, Wang Y, Maggs DG, Kolterman OG, Chandran M, Mudaliar SR, Henry RR.

Diabetes Care. 2003 Jan;26(1):1-8.PMID: 12502651 [PubMed - indexed for MEDLINE]Related articlesFree article

The controversy of the treatment of critically ill patients with thyroid hormone.

Stathatos N, Levetan C, Burman KD, Wartofsky L.

Best Pract Res Clin Endocrinol Metab. 2001 Dec;15(4):465-78. Review.PMID: 11800518 [PubMed - indexed for MEDLINE]Related articles

Impact of computer-generated personalized goals on HbA(1c).

Levetan CS, Dawn KR, Robbins DC, Ratner RE.

Diabetes Care. 2002 Jan;25(1):2-8.PMID: 11772893 [PubMed - indexed for MEDLINE]Related articlesFree article

Hospital management of diabetes.

Levetan CS, Magee MF.

Endocrinol Metab Clin North Am. 2000 Dec;29(4):745-70. Review.PMID: 11149160 [PubMed - indexed for MEDLINE]Related articles

Effect of physician specialty on outcomes in diabetic ketoacidosis.

Levetan CS, Passaro MD, Jablonski KA, Ratner RE.

Diabetes Care. 1999 Nov;22(11):1790-5.PMID: 10546009 [PubMed - indexed for MEDLINE]Related articlesFree article

Unrecognized diabetes among hospitalized patients.

Levetan CS, Passaro M, Jablonski K, Kass M, Ratner RE.

Diabetes Care. 1998 Feb;21(2):246-9.PMID: 9539990 [PubMed - indexed for MEDLINE]Related articlesFree article

Radiation therapy of metastatic pheochromocytoma: case report and review of the literature.

Yu L, Fleckman AM, Chadha M, Sacks E, Levetan C, Vikram B.

Am J Clin Oncol. 1996 Aug;19(4):389-93. Review.PMID: 8677912 [PubMed - indexed for MEDLINE]Related articles

Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes.

Levetan CS, Salas JR, Wilets IF, Zumoff B.

Am J Med. 1995 Jul;99(1):22-8.PMID: 7598138 [PubMed - indexed for MEDLINE]Related articles

A clinical guide to the management of Graves' disease with radioactive iodine.

Levetan C, Wartofsky L.

Endocr Pract. 1995 May-Jun;1(3):205-12.PMID: 15251595 [PubMed]Related articles